Återgå till huvudnavigering
Återgå till sök
Gå direkt till huvudinnehållet
Lunds universitet Hem
English
Svenska
Hem
Profiler
Forskningsoutput
Projekt
Enheter
Infrastruktur
Aktiviteter
Priser och utmärkelser
Sök efter expertis, namn eller tillhörighet
Jonas Ahl
Knuten till universitetet
Docent, Specialistläkare
,
Klinisk mikrobiologi, Malmö
Forskare, Docent
,
Klinisk infektionsmedicin
Telefon
+4640331771
E-postadress
jonas.ahl
med.lu
se
Översikt
Fingeravtryck
Nätverk
Forskningsoutput
(30)
Projekt
(5)
Liknande profiler
(12)
Handlett arbete
(2)
Fingeravtryck
Utforska forskningsämnen där Jonas Ahl är aktiv. Dessa ämnesetiketter kommer från personens arbeten. Tillsammans bildar de ett unikt fingeravtryck.
Sortera efter
Vikt
Alfabetisk ordning
Medicine and Dentistry
Streptococcus Pneumoniae
100%
Patient
71%
Therapeutic Procedure
38%
Child
33%
Antiinfective Agent
27%
Community-Acquired Pneumonia
26%
Blood Vessel Graft
26%
Culture
21%
Antibiotics
21%
Adult
21%
Personnel
20%
Hospital
18%
Retrospective Study
17%
Mortality
15%
Pathogen
14%
Nursing Home
13%
Aspiration
13%
Breast Cancer
13%
Tumor Progression
13%
Membrane Vesicle
13%
Acute Otitis Media
13%
Neutrophil
13%
Retrospective Cohort Study
13%
Conservative Treatment
13%
Age
12%
Symptom
10%
Antimicrobial Therapy
10%
Follow up
7%
Morbidity
6%
Cohort Effect
6%
Resident
6%
Antibiotic Therapy
6%
Combination Therapy
6%
RNA 18S
5%
Immunology and Microbiology
Serotype
60%
Pneumococcal Vaccine
43%
Infectious Agent
34%
Extended Spectrum Beta Lactamase Producing Escherichia Coli
26%
Haemophilus influenzae
24%
Bacterium
24%
Growth
18%
Bronchoalveolar Lavage Fluid
16%
Penicillin
14%
Titer
13%
Lineages
13%
Virus
13%
Otitis Media
13%
Pneumococcus
13%
Spectrum
13%
Innate Immune System
13%
Antigen
9%
Mouse
9%
Monospecific Antibody
7%
Extended Spectrum Beta Lactamase Producing Enterobacteriaceae
6%
Pilus
6%
Polymerase Chain Reaction
5%
Immunity
5%
Adaptive Immune System
5%
Pharmacology, Toxicology and Pharmaceutical Science
Respiratory Tract
39%
Streptococcus Pneumoniae
26%
Community Acquired Pneumonia
26%
Infection
26%
Ventilator Associated Pneumonia
18%
Antibiotics
14%
Pneumonia
14%
Staphylococcal Bacteremia
13%
Multiple Drug Resistance
13%
Incidence
13%
Prospective Study
13%
Case-Control Study
13%
Amoxicillin
13%
Clindamycin
9%
Erythromycin
8%
Penicillin G
8%
Minimum Inhibitory Concentration
8%
Antibiotic Therapy
7%
4 Aminobutyric Acid
6%
Antimicrobial Resistance
6%
Penicillin Derivative
6%
Pneumococcus Vaccine
6%
Retrospective Study
5%